Sure as long as you can provide absolute proof that it will work. You can't work out mathematically what CG is worth but think about this: Burstein got C$1.25 mio for 49% of MGC derma and MXC got C$11.25 mio for 51%. Does that sound strange to you? Using MXC's numbers, then you are looking at CG being worth around C$100 mio. Now you might think that a company with that sort of valuation may have some public exposure, wouldn't you think?I hope that makes the discussion easier!
As you have said in a later post "Maybe wait until we get all the details before making your assessment."
